Exenatide PPT Template: Medical Animated PowerPoint
The Exenatide PPT template is an animated medical PowerPoint designed by RxSlides' team of healthcare professionals.
This dynamic template has animation to simplify the mechanisms of Exenatide, transforming complex medical concepts into clear and engaging visuals.
Your audience will see Exenatide’s journey through the body, its interaction with receptors and its ultimate impact on blood sugar control; all brought to life through impressive animations.
Simplify medical processes with step-by-step animated sequences, ensuring your audience understands even the most complex details of Exenatide's action.
Content of Exenatide PPT Template
Exenatide covers slides for Exenatide PPT template with different impressive illustrations for Exenatide subcutaneous injection prefilled pen and blood sugar level measurements.
Medical overview
The medical overview section in the Exenatide PPT template has introductory topics about pancreas anatomy and the standard mechanism of insulin secretion.
Illustrated pancreatic anatomy includes the gall bladder, bile duct, duodenum, head, tail and body.
Illustrations for pancreas histology with islets of Langerhans, Pp cells, delta cells, alpha cells, beta cells and pancreatic acini
You can notice that we added an animated explanation for glucose-dependent insulin secretion.
The animation explains that blood glucose levels are elevated after a meal. It enters beta cells by GLUT1-3 and then gets metabolized, producing ATP, which binds to KATP.
Binding results in KATP blocking and causing the cell membrane to become depolarized, which opens ca+2 voltage-gated channels, causing the ca+2 influx into the cell.
The animation explains that Ca+2 influx stimulates exocytosis and the release of insulin.
Exenatide drug overview
The Exenatide PPT template slides cover the following topics:
Chemical structures of glucose-like peptide 1 and Exenatide and the difference between them.
The exenatide class is increasing mimetics. Exenatide is a self-regulating drug that lowers blood sugar levels when they are elevated but doesn't continue to lower blood sugar when levels return to normal, unlike sulfonylureas and insulin.
Illustration for exenatide dosage forms: the drug comes as a prefilled pen for subcutaneous injection with 60 subcutaneous doses with 5 mcg per dose or 10 mcg per dose.
drug administration is illustrated as a subcutaneous injection.
The drug is available on the market under the brand name Byetta Injection and is produced by Amylin Pharmaceuticals, Inc.
Exenatide pharmacokinetics
The exenatide pharmacokinetics section in the Exenatide PPT template has an illustration explaining the apparent volume of distribution of the drug.
Medical infographics and general pharmacokinetics graphs can be used to visualize the half-life and capsulated microsphere disintegration of the drug.
Animated exenatide mechanism of action
You can notice that the mechanism of action of Exenatide is animated, starting with an explanation of the incretin’s mechanism.
The illustration shows that the incretins are secreted when the glucose blood level is high; they bind to GLP-1 receptors, causing the Gs subunit to activate adenylyl cyclase, which converts ATP to cAMP, which causes exocytosis of insulin secretion.
Exenatide is an incretin mimetic, so, as illustrated, it is acting with the exact mechanism of action.
Exenatide indications
Exenatide is indicated in type 2 diabetes.
Exenatide side effects
The exenatide side effects section has animated icons of nausea, vomiting, headache, diarrhea, constipation, dyspepsia and headaches.
Exenatide contraindications (h3)
Exenatide contraindications are hypersensitivity and thrombocytopenia and cases to take caution with when taking Exenatide are kidney diseases, pancreatic diseases and gastric diseases.
Monitoring parameters required when taking Exenatide are creatinine at baseline and then periodically.
According to the National Institute of Health (NIH), Exenatide is not recommended in patients with end-stage renal disease or severe renal impairment (creatinine clearance <30 mL/min).
These contraindications and precautions are explained with illustrations, graphs and medical infographics in this Exenatide PPT template.
Clinical studies section template
In this section of the Exenatide PPT template, we provide you with a variety of medical infographics, charts and medical graphs to use in visualizing your data from different clinical studies.
Exenatide-drug interaction
The drug may increase cidofovir level, increase the risk of myeloid suppression, cause nephrotoxicity and cause other side effects.
The drug with potassium solid formulations may increase the risk of gastrointestinal ulceration, stenotic lesions, gastrointestinal transient delay and increased local exposure to high potassium concentrations.
Different medical infographics and illustrations are used to visualize these interactions.
RxSlides visuals for exenatide PowerPoint template
You can notice that RxSlides provides you with a set of PowerPoint icons and illustrations related to Exenatide that will help you customize the content of this 100% editable presentation according to your content and audience interest.
You can use the diabetic graphs and infographics available in our diabetes PPT template to customize your Exenatide PowerPoint presentation.
Features of the Template
- 100% editable PowerPoint template. - Editable colors, you can change according to your presentation style and company branding guidelines.
Purchase Template
Purchase the fully editable PowerPoint open file template
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.